Tianren Pharmaceutical is determined to become an internationally advanced

Chemical raw materials production and research base.

News Center

May 2022! The execution time of the sixth batch of national procurement is determined
2022-01-06 14:25:34

On January 6, Shanghai Sunshine Pharmaceutical Procurement Network issued the "Notice on Announcement of the First-Year Agreement Procurement Quantity of National Centralized Drug Procurement (Insulin Special Project). The notice stipulates that the results of this insulin special procurement will be implemented in May 2022, and the specific implementation date shall be subject to the notice issued by various places.


According to the notice, all pharmaceutical institutions have completed the confirmation of the procurement volume of the selected products for insulin in accordance with the provisions of the "National Centralized Procurement Document (Insulin Special Project) (GY-YD2021-3)". The national first-year agreement procurement volume and the first-year agreement procurement volume of various regions have been determined.


It is reported that the sixth batch of national procurement has been completed. From the official launch of the sixth batch of national procurement (insulin special project) on September 10, 2021 to the current implementation time of the winning results is determined, which is less than half a year.


Attached from the original text:


Notice on the Announcement of the First-Year Agreement Procurement of National Centralized Drug Procurement (Insulin Special Project)


All relevant units:


In accordance with the work arrangement, all pharmaceutical institutions have completed the confirmation of the procurement volume of the selected products for insulin in accordance with the provisions of the "National Centralized Procurement Document (Insulin Special Project) (GY-YD2021-3)". The national first-year agreement procurement volume and the first-year agreement procurement volume of various regions have been determined.


Medical insurance departments in each province can log in to the "National Organization of Comprehensive Service Platform for Centralized Procurement of Drugs" (website:http://pub.smpaa.cn/ydsblxt/), click the "Agreement Purchase Volume View" menu in "Agreement Purchase Volume Management" on the left to view the agreement purchase volume of the insulin selected enterprises in this province.


All insulin selected companies can log in to the "National Organization's Comprehensive Service Platform for Centralized Procurement of Drugs" (Website:http://pub.smpaa.cn/xxsj/), click the "Agreement Purchase Quantity View" menu in "National Procurement Bidding Management" on the left to view the agreement purchase volume of the selected products of this company.


The results of this insulin special procurement will be implemented in May 2022. The specific implementation date shall be subject to the notice issued by various places.


Hereby notify.


National Organization of Joint Procurement Office of Drugs


January 6, 2022      


Related tags:

Comment

(0)
*Captcha:
CONTACT ADDRESS
Address: No. 509, East Lin Road, Biological Industry Park, Yichang High-tech Zone

Fax:0717-6555394

CALL CENTER
Domestic Marketing Department

Tel: 0717-6555750 0717-6555395

Fax: 0717-6555395

Contact: Mr. Zhang 13872497275

Email: yctianrenrxport@163.com

Contact: Kaifeng Zhang 19986669868

Email: 18348704@qq.com



CALL CENTER
International Marketing Department

Tel: 0717-6555905

Fax: 0717-6555395

Contact: Miao Guo 15997560212

Email: vivian.guo@tianrenpharm.com

Copyright@Yichang Tianren Pharmaceutical Co., Ltd. All rights reserved Hubei ICP No. 19029711-2 Hubei Public Security No. 42050202000636 Mainly focuses on the research, development, production and sales of chemical raw materials and pharmaceutical intermediates. Welcome to call for consultation!

Technical support: Guosheng Technology

This website uses cookies to ensure you get the best experience on our website.

Accept Reject